US Weekly IPO and SPAC Monitor: Intel’s Mobileye Filed for an IPO in Quiet Period

No surprise after the disaster of the three major US stock indexes ugly closes Friday to finish off a disastrous September and the IPO market there are currently no IPOs scheduled for the first week of October. The biggest news of the week came from Intel’s Mobileye (MBLY), which filed for an IPO we estimate could raise up to $2.5 billion. The third quarter was worst third quarter for new issuers in over a decade, with 25 IPOs raising $2.4 billion as … Continue reading “US Weekly IPO and SPAC Monitor: Intel’s Mobileye Filed for an IPO in Quiet Period”

US Weekly IPO and SPAC Monitor: Biotech Intensity Therapeutics, Chinese YanGuFang and Japanese Lead Real Estate

Coming into end of quarter IPO pricing expect from two Asian issuers and a biotech. Chinese producer of oat and grain products YanGuFang (YGF), Japanese luxury real estate developer Lead Real Estate (LRE) and Oncology biotech Intensity Therapeutics (INTS).  There may also be a number of small deals that have been expected but have not priced. Another quiet week as IPO continue to dry up in this risk off market. One NYSE American uplisting Loop Media (LPTV) priced at the … Continue reading “US Weekly IPO and SPAC Monitor: Biotech Intensity Therapeutics, Chinese YanGuFang and Japanese Lead Real Estate”

US Weekly IPO and SPAC Monitor: Biotechs Jupiter Neurosciences and Alopexx with Laser Photonics

The IPO issuance slows down in the week ahead after AIG spin Corebridge Financial (CRBG) was the biggest IPO of 2022 thus far.  Three small deals may price in the week ahead, Neuro-inflammation biotech Jupiter Neurosciences (JUNS) is the largest. Two nano-caps may price in the week ahead, infectious disease biotech Alopexx (ALPX) and laser-based system maker Laser Photonics (LASE). Last week six issuers began trading, AIG spin-off Corebridge $CRBG, the largest deal of 2022. Third Harmonic Bio (THRD) upsized, Nexalin Technology (NXL) … Continue reading “US Weekly IPO and SPAC Monitor: Biotechs Jupiter Neurosciences and Alopexx with Laser Photonics”